Global In-Vitro Fertilization (IVF) Market Value Get over US$ 38.7 bn by 2020-2027

According to the Acumen Research and Consulting, the global In-Vitro Fertilization (IVF) market is expected to reach at US$ 38.7 billion by 2026, along with the projected CAGR of 9.8 % from 2020-2026.

The published report global In-Vitro Fertilization (IVF) market provides a holistic overview of the current market covering the current trends. The provided quantitative and qualitative data is based on the deeper analysis of the historical data and the current market situation that helps to provide an overview of the forecasted period.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1278

The global In-Vitro Fertilization (IVF) market report provides deeper insights on the factors driving the global market along with the factors that are responsible to hamper the growth. In addition, the report provides the opportunities in the global In-Vitro Fertilization (IVF) market that would help the competitors to increase the profit share.

The global In-Vitro Fertilization (IVF) market report provides the quantitative information of the target segment that is covered in the report along with the regional data comparison.

The report provides an overview value chain analysis, Porters Five analysis, and cost structure analysis gives an idea of the industrial outlook. The global In-Vitro Fertilization (IVF) market report covers the data of the major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the report also covers the country cross section providing deeper insights of the particular region.

The published global In-Vitro Fertilization (IVF) market report provides information about the major players operating in the target market. The company profile section provides important information about the major players, along with the financial overview, product segment revenue, the geographical presence of the company. It also provides information related to business development activities by the players such as merger & acquisition, partnerships and agreements.

The global In-Vitro Fertilization (IVF) market report also covers the products information that is offered by the particular players along with the specification. In addition, the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.

Market participants

EMD Serono Inc.; OvaScience; Genea Biomedx; Vitrolife AB; Irvine Scientific; Thermo Fisher Scientific Inc.; Cook Medical Inc.; Cooper Surgical Inc.; Boston IVF, and Progyny, Inc.

Market segmentation

In-Vitro Fertilization (IVF) Market by Instrument

Culture Media
Disposable Devices
Capital Equipment

In-Vitro Fertilization (IVF) Market by Type

Frozen Non-donor
Fresh Non-donor
Frozen Donor
Fresh Donor

In-Vitro Fertilization (IVF) Market by End-Use

Fertility Clinics
Hospitals & others

Global In-Vitro Fertilization (IVF) Market, by Geography

North America

U.S.
Canada
Mexico

Europe

UK
Germany
France
Rest of Europe

Asia-Pacific

China
Japan
India
Australia
Rest of Asia-Pacific

Latin America

Brazil
Chile
Rest of Latin America

Middle East and Africa (MEA)

South Africa
Saudi Arabia
Rest of MEA

Table of content

CHAPTER 1. Industry Overview
1.1. Definition and Scope
1.1.1. Definition of In-Vitro Fertilization (IVF)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. In-Vitro Fertilization (IVF) Market By Instrument
1.2.2.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By Instrument (2015-2026)
1.2.2.2. Global In-Vitro Fertilization (IVF) Market Revenue Share By Instrument in 2017
1.2.2.3. Culture Media
1.2.2.4. Disposable Devices
1.2.2.5. Capital Equipment
1.2.2.6. Others
1.2.3. In-Vitro Fertilization (IVF) Market By Type
1.2.3.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.3.2. Frozen Non-donor
1.2.3.3. Fresh Non-donor
1.2.3.4. Frozen Donor
1.2.3.5. Fresh Donor
1.2.3.6. Others
1.2.4. In-Vitro Fertilization (IVF) Market By End Users
1.2.4.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Fertility Clinics
1.2.4.3. Hospitals
1.2.4.4. Others
1.2.5. In-Vitro Fertilization (IVF) Market by Geography
1.2.5.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. Market Dynamics And Competition Analysis
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. Manufacturing Plants Analysis
3.1. Capacity and Commercial Production Date of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
CHAPTER 4. In-Vitro Fertilization (IVF) Market By Instrument
4.1. Global In-Vitro Fertilization (IVF) Revenue By Instrument
4.2. Culture Media
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Disposable Devices
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Capital Equipment
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Other
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. In-Vitro Fertilization (IVF) Market By Type
5.1. Global In-Vitro Fertilization (IVF) Revenue By Type
5.2. Frozen Non-donor
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Fresh Non-donor
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Frozen Donor
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Fresh Donor
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. In-Vitro Fertilization (IVF) Market By End Users
6.1. Global In-Vitro Fertilization (IVF) Revenue By End Users
6.2. Fertility Clinics
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 7. North America In-Vitro Fertilization (IVF) Market By Country
7.1. North America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. In-Vitro Fertilization (IVF) Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
CHAPTER 8. Europe In-Vitro Fertilization (IVF) Market By Country
8.1. Europe In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
CHAPTER 9. Asia-Pacific In-Vitro Fertilization (IVF) Market By Country
9.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
CHAPTER 10. Latin America In-Vitro Fertilization (IVF) Market By Country
10.1. Latin America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
CHAPTER 11. Middle East In-Vitro Fertilization (IVF) Market By Country
11.1. Middle East In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
CHAPTER 12. Africa In-Vitro Fertilization (IVF) Market By Country
12.1. Africa In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Africa In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Instrument, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
CHAPTER 13. Company Profile
13.1. EMD Serono Inc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. OvaScience
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Genea Biomedx
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Vitrolife AB
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Irvine Scientific
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Thermo Fisher Scientific Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Cook Medical Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Cooper Surgical Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Boston IVF
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Progyny, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
CHAPTER 14. Research Approach
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1278

Contact us:

Sheetal k

Email: [email protected]

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com